Positive inotropic agents in congestive heart failure.
Homoud
M K
MK
Department of Medicine, New England Medical Center, Boston, MA 02111.
Chuttani
K
K
Konstam
M A
MA
D000322:Adrenergic Agonists / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D002302:Cardiac Output / Q000187:drug effects; D002316:Cardiotonic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D015996:Survival Rate
D000322:Adrenergic Agonists; D002316:Cardiotonic Agents; D010726:Phosphodiesterase Inhibitors